Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Additional Antiplatelet Therapy in the Ischemic Stroke With Atrial Fibrillation and Co-morbiD Atherosclerosis During edOxaban treatmeNt. (ADD-ON) Study, Multicenter Registry-based Analysis

NCT04010955 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT04010955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04010955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Additional Antiplatelet Therapy in the Ischemic Stroke With Atrial Fibrillation and Co-morbiD Atherosclerosis During edOxaban treatmeNt. (ADD-ON) Study, Multicenter Registry-based Analysis
Lead sponsor
Asan Medical Center
Phase
Observational
Overall status
Active, not recruiting
Start date
October 8, 2019
Completion date
June 27, 2026
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, anticoagulant, antiplatelet, atrial fibrillation, coronary artery atherosclerosis, extracranial atherosclerosis, intracranial atherosclerosis, peripheral artery stenosis